Android app on Google Play

Stifel Nicolaus Upgrades Salix Pharmaceuticals (SLXP) to Buy

December 17, 2013 6:59 AM EST Send to a Friend
Get Alerts SLXP Hot Sheet
Price: $154.56 --0%

Rating Summary:
    16 Buy, 10 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 20 | Down: 16 | New: 28
Trade SLXP Now!
Join SI Premium – FREE
Stifel Nicolaus upgraded Salix Pharmaceuticals (NASDAQ: SLXP) from Hold to Buy with a price target of $108.00.

For an analyst ratings summary and ratings history on Salix Pharmaceuticals click here. For more ratings news on Salix Pharmaceuticals click here.

Shares of Salix Pharmaceuticals closed at $84.80 yesterday.




You May Also Be Interested In


Related Categories

Upgrades

Related Entities

Stifel Nicolaus

Add Your Comment